Revance Therapeutics Inc. (RVNC)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
D E ShawNOTE 1.750% 2/1

D. E. Shaw

27,330,000 $26,160,973 +59% 0.01%
2.
Graham Capital ManagementNOTE 1.750% 2/1

Kenneth Tropin

26,429,000 $25,366,951 -28% 0.38%
3.
Indaba Capital ManagementNOTE 1.750% 2/1

Derek C. Schrier

25,000,000 $24,030,000 11.57%
4.
Beryl Capital Management

David Alexander Witkin

5,935,009 $18,042,427 4.07%
5.
Squarepoint Ops LLC

Maxime Fortin (Cio)

3,164,943 $9,621,427 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.98 30,000 Officer, Director 1,015,468 2024-03-06 Filing
$15.74 6,400 Director 26,913 2021-12-13 Filing
$14.43 30,000 Officer, Director 95,463 2021-12-03 Filing
$12.90 40,000 Officer, Director 110,913 2021-11-29 Filing
$31.20 900 Director 6,150 2018-03-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.17 3,908 Officer 104,945 2024-11-18 Filing
$3.80 2,392 Officer 114,864 2024-04-16 Filing
$5.04 9,211 Officer 167,550 2024-03-18 Filing
$5.04 8,125 Officer 137,815 2024-03-18 Filing
$5.04 9,361 Officer 192,666 2024-03-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 60,543 $57,894,243 2.25%
2. 40,000,000 $38,300,000 3.03%
3. 24,950,000 $34,534,152 7.42%
4. 8,597,418 $26,136,151 0%
5. 19,832,000 $18,964,347 0.41%
News See All